A phase 2 study of the WEE1 inhibitor AZD1775 in <i>SETD2</i>-deficient advanced solid tumor malignancies.Edward Maldonado, Rahul Aggarwal, Geoffrey I. Shapiro et al.|Journal of Clinical Oncology|2023Cited by 3